Eugia Recalls One Lot of Vancomycin for Injection Nationwide: Lot 3VM26026A, 1.25 Grams per Vial, Expiring July 2028, After a Glass Particle Was Found Inside a Vial, With No Adverse Events Reported
Washington — A company notice posted by the Food and Drug Administration on November 9 says Eugia US LLC is recalling one lot of Vancomycin Hydrochloride for Injection USP nationwide after a glass particle was found inside a vial.
The recalled product is the 1.25 gram, 30 milliliter single dose vial, lot 3VM26026A, with an expiration date of July 2028. The carton National Drug Code is 55150-471-10 and each vial carries 55150-471-01.
The lot was shipped to wholesalers nationwide from September 2 to September 15, 2026. The company announced the recall on November 6 and the FDA posted it on November 9. The recall extends to the hospital, health care facility and user level.
The notice posted by the FDA warns that use of product containing glass particulates can cause serious adverse health consequences. The company said it has received no reports of adverse events tied to the recall to date.
Health problems that may be linked to the product can be reported to the FDA MedWatch program online, by mail or by fax. This report relays only the facts in the recall notice and the official reporting channel, without individual medication advice.
Published by GSM · USA (original Chinese edition)
Photo: Wikipedia/Wikimedia Commons 词条主图：Lot One
CDC Updates Measles Data on November 6: 5,182 Confirmed Cases in 2026 as of November 5, With 43 New Outbreaks and 96 Percent of Cases Outbreak Associated2026-11-10
Bechtel Medical Wound VOX Receives FDA 510(k) Clearance: The First Cleared System Combining Negative Pressure and Topical Oxygen Therapy, With a Limited Release in December2026-11-10